Shanghai LePure Biotech Co., Ltd.
PrivateLast Round
Series C
Jan 17, 2023
Est. Valuation
$261.54M
Total Funding Raised
$125.55M
Company Overview
Shanghai LePure Biotech Co., Ltd. is a biotechnology company that provides single-use bioprocessing solutions, including consumables, equipment, and validation services, for the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotech Equipment, Clean Manufacturing, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai LePure Biotech Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Shanghai LePure Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 17, 2023 | ||||
| Strategic | Nov 25, 2022 | ||||
| Strategic | Jul 18, 2022 | ||||
| VC Round | Feb 18, 2022 | ||||
| Series B Extension | Dec 18, 2021 | ||||
Series B | Apr 2, 2021 |
Shanghai LePure Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | VC Round, Series C, Strategic |
| Hillhouse Investment | Series B Extension |
| Goldman Sachs (Asia) LLC | Strategic |
| Huimei Capital | Strategic, Series B Extension, Series C |
| Goldman Sachs Asset Management Private Equity | Series C |
| Legend Capital | Series B Extension, Series B |
| CICC Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2023
$126M round led by Goldman Sachs, Novo Holdings, and General Atlantic.
- Nov 25, 2022
Raised a strategic round with participation from Huimei Capital.
Shanghai LePure Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai LePure Biotech Co., Ltd.'s valuation, stock price, and market status.